If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

18 Sep 2013 07:00

RNS Number : 2114O
Standard Life Euro Pri Eqty Tst PLC
18 September 2013
 



 

 

 

 Standard Life European Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2013

 

· NAV rose by 1.4% to 247.3p for the quarter ended 30 June 2013

· NAV total return was up 8.1% for the six months starting 1 January 2013

· Realised gains and income during the quarter ended 30 June 2013 were £7.1 million (1.8% of NAV). The unrealised losses on the portfolio on a constant exchange rate basis were £4.8 million (1.2% of NAV); in addition, there were unrealised foreign exchange gains of £4.2 million (1.1% of NAV).

· 100.0% by value of the portfolio was valued by the respective underlying managers at 30 June 2013

· Outstanding commitments were £197.4 million at 30 June 2013

· Net cash was £27.7 million at 30 June 2013

 

For the quarter ended 30 June 2013 the Company's net asset value per ordinary share ("NAV") rose by 1.4% to 247.3p (diluted - 244.2p), from 243.9p (diluted - 240.9p) at 31 March 2013. At 30 June 2013 the Company's net assets were £400.0 million (31 March 2013 - £394.5 million).

 

The volume of new transactional activity remained subdued in the European private equity market in the second quarter of 2013, due to the challenging macro-economic and political environment in Europe. However, supported by increased liquidity in the leveraged debt markets the value of new transactions rose markedly, with a notable rise in the number of large and mega buy-outs. A total of €26.5 billion of transactions by enterprise value was reported during the quarter, which was materially higher than the €10.4 billion reported in the first quarter of 2013. The Manager also continued to see exit activity across the Company's portfolio as private equity managers focused on selling, or in some instances re-capitalising, investee companies.

 

The closing value of the Company's portfolio of 41 private equity fund interests was £374.3 million at 30 June 2013 (31 March 2013 - £375.7 million). The total unrealised losses on the portfolio for the quarter ended 30 June 2013 were £0.6 million, of which £4.8 million were unrealised losses on a constant exchange rate basis and £4.2 million were unrealised foreign exchange gains. The £4.8 million of losses in the value of the portfolio on a constant exchange rate basis reflected weaker listed equity markets, partially offset by positive earnings growth at many underlying portfolio companies. The MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) fell by 3.2% and 2.7% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro appreciating by 1.3% relative to sterling over the quarter.

 

During the quarter the Company funded £7.5 million of draw downs (six months ended 31 March 2013 - £21.1 million) and received £15.5 million of distributions (six months ended 31 March 2013 - £28.5 million). The distributions received generated £7.1 million of realised gains and income, which was equivalent to a return of 1.9 times the acquisition cost of the realised investments.

 

On 28 June 2013 the Company made a new primary fund commitment of €30.0 million to CVC Capital Partners VI. The Company has invested in five prior funds of the manager, CVC Capital Partners.

 

The Company had total outstanding commitments of £197.4 million at 30 June 2013 (31 March 2013 - £177.3 million). At 30 June 2013 the Company had a cash balance of £27.7 million (31 March 2013 - £21.5 million).

 

 

2. Activity since 30 June 2013

 

During the period from 30 June 2013 to 17 September 2013 the Company funded £9.4 million of draw downs and received £13.9 million of distributions. The Company made no new primary fund commitments during the period, however, the Company completed the purchase of an original commitment of €10 million to Bridgepoint Europe IV in July 2013. The fund interest was acquired at a 4% discount to the 31 December 2012 valuation of the fund, adjusted for subsequent cashflows. The purchase price for the fund interest was £7.4 million and the Company assumed £1.6 million of outstanding commitments.

 

In addition, the Company completed the sale of its remaining original commitment of €30 million to Charterhouse VIII in August 2013. The fund interest was sold at a 2% discount to the 31 March 2013 valuation of the fund, adjusted for subsequent cashflows. The sale price for the interest was £18.5 million and the Company was released from £3.4 million of outstanding commitments.

 

Accordingly, at 17 September 2013 the Company's total outstanding commitments and cash balance were £181.6 million and £40.5 million respectively.

 

It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2013 on or around 28 November 2013.

 

 

For further information please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXDLFFXKFBBBE
Date   Source Headline
1st Jul 200911:19 amRNSTotal Voting Rights
30th Jun 20093:31 pmRNSDirector/PDMR Shareholding
26th Jun 20099:00 amRNSIssue of Equity
9th Jun 200912:17 pmRNSDirector/PDMR Shareholding
3rd Jun 20092:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200910:20 amRNSDirector/PDMR Shareholding
29th May 20097:00 amRNSHalf Yearly Report
24th Mar 20097:30 amRNSTrading Statement
24th Feb 200910:15 amRNSSecondary Sales
3rd Feb 20092:37 pmRNSHolding(s) in Company
2nd Feb 200912:37 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:34 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:30 pmRNSTotal Voting Rights
2nd Feb 200911:23 amRNSHolding(s) in Company
27th Jan 200910:10 amRNSIssue of Shares following Scrip Dividend
26th Jan 20094:20 pmRNSInterim Management Statement
26th Jan 20094:08 pmRNSResult of AGM
26th Jan 200912:19 pmRNSDirectorate Change
14th Jan 20097:00 amRNSDisposal of Private Equity Fund Interests
8th Jan 20093:00 pmRNSScrip Dividend reference price
5th Jan 20094:05 pmRNSAnnual Financial Report
5th Jan 20094:00 pmRNSAnnual Information Update
18th Dec 20084:00 pmRNSAppointment of Broker
18th Dec 200811:46 amRNSDirector/PDMR Shareholding
17th Dec 20082:43 pmRNSDoc re. Annual Report
4th Dec 20084:49 pmRNSDirector/PDMR Shareholding
1st Dec 20087:00 amRNSFinal Results
27th Nov 20082:21 pmRNSDirectorate Change
23rd Sep 20087:00 amRNS3rd Quarter Trading Statement
22nd Sep 20082:37 pmRNSResult of EGM
22nd Aug 20087:00 amRNSCircular re EGM
30th Jul 20084:42 pmRNSSecond Price Monitoring Extn
30th Jul 20084:36 pmRNSPrice Monitoring Extension
24th Jul 20087:30 amRNSInterim Management Statement
15th Jul 20084:37 pmRNSDirector/PDMR Shareholding
30th Jun 200810:16 amRNSDirector Declaration
17th Jun 20084:22 pmRNSDoc re. Interim Report
30th May 20087:00 amRNSInterim Results
20th May 20083:18 pmRNSHolding(s) in Company
18th Mar 20082:58 pmRNSDirector/PDMR Shareholding
18th Mar 20087:00 amRNSTrading Statement
30th Jan 200810:31 amRNSDirector/PDMR Shareholding
29th Jan 20089:00 amRNSInterim Management Statement
28th Jan 20084:20 pmRNSResult of AGM
10th Jan 200810:31 amRNSAnnual Information Update
3rd Jan 200810:23 amRNSPortfolio Update
3rd Jan 200810:21 amRNSTotal Voting Rights
27th Dec 200710:33 amRNSDirector/PDMR Shareholding
20th Dec 20072:00 pmRNSDoc re. Annual Report
28th Nov 20077:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.